Stock Scorecard
Stock Summary for Establishment Labs Holdings Inc (ESTA) - $48.54 as of 4/26/2024 3:12:16 PM EST
Total Score
3 out of 29
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for ESTA
Positive earnings growth | |
P/E ratio less than Industry P/E Ratio | |
P/E ratio less than Sector P/E Ratio | |
P/E ratio that is half the growth rate (or less) | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Positive net income past year and 12 trailing months | |
Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for ESTA
Revenue growing by at least 20% average per year over the last 5 years | |
Market Capitalization under 2 billion | |
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for ESTA
Declared an ex-dividend date | |
Forward annual dividend rate greater than 2 | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Current ratio most recent quarter greater than 2 |
Bonus Criteria for ESTA
P/E ratio less than five-year Average P/E ratio | |
Last Price to 52 Week Low Ratio Less Than 1 | |
Total Cash Per Share > Last Day Price | |
P/S Ratio < 1 | |
P/B Ratio < 1 |
Latest News for for ESTA
Financial Details for ESTA
Company Overview |
|
---|---|
Ticker | ESTA |
Company Name | Establishment Labs Holdings Inc |
Country | USA |
Description | Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for cosmetic and reconstructive plastic surgery. The company is headquartered in Alajuela, Costa Rica. |
Sector Name | LIFE SCIENCES |
Industry Name | ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES |
Most Recent Quarter | 12/31/2023 |
Next Earnings Date | 5/24/2024 |
Stock Price History |
|
Last Day Price | 48.54 |
Last Day Price Updated | 4/26/2024 3:12:16 PM EST |
Last Day Volume | 0 |
Average Daily Volume | 317,069 |
52-Week High | 73.00 |
52-Week Low | 16.96 |
Last Price to 52 Week Low | 186.20% |
Valuation Measures |
|
Trailing PE | N/A |
Industry PE | 60.69 |
Sector PE | 56.64 |
5-Year Average PE | -18.40 |
Free Cash Flow Ratio | 33.25 |
Industry Free Cash Flow Ratio | 37.87 |
Sector Free Cash Flow Ratio | 30.65 |
Current Ratio Most Recent Quarter | 3.06 |
Total Cash Per Share | 1.46 |
Book Value Per Share Most Recent Quarter | 0.70 |
Price to Book Ratio | 75.06 |
Industry Price to Book Ratio | 6.35 |
Sector Price to Book Ratio | 22.15 |
Price to Sales Ratio Twelve Trailing Months | 8.36 |
Industry Price to Sales Ratio Twelve Trailing Months | 7.00 |
Sector Price to Sales Ratio Twelve Trailing Months | 5.17 |
Share Statistics |
|
Total Shares Outstanding | 27,459,700 |
Market Capitalization | 1,332,893,838 |
Institutional Ownership | N/A |
Dividends |
|
Ex-Dividend Date | N/A |
Last Dividend Amount | 0.00 |
Current Dividend Amount | 0.00 |
Dividend Aristocrat? | False |
Trailing Annual Dividend Rate | 0.00 |
Trailing Annual Dividend Yield | 0.00% |
Forward Annual Dividend Rate | 0.00 |
Forward Annual Dividend Yield | 0.00% |
5-Year Dividend Payments Count | 0 |
3-Year Average Dividend Yield | 0.00% |
5-Year Average Dividend Yield | 0.00% |
1-Year Dividend Growth Rate Percentage | 0.00% |
3-Year Dividend Growth Rate Percentage | 0.00% |
5-Year Dividend Growth Rate Percentage | 0.00% |
All-Time Dividend Growth Rate Percentage | 0.00% |
Dividend Payout Ratio | N/A |
Income Statement |
|
Quarterly Earnings Growth YOY | 0.00% |
Annual Earnings Growth | -4.38% |
Reported EPS 12 Trailing Months | -3.07 |
Reported EPS Past Year | 0.00 |
Reported EPS Prior Year | -3.04 |
Net Income Twelve Trailing Months | -78,502,000 |
Net Income Past Year | -78,502,000 |
Net Income Prior Year | -75,209,000 |
Quarterly Revenue Growth YOY | -28.00% |
5-Year Revenue Growth | 21.96% |
Balance Sheet |
|
Total Cash Most Recent Quarter | 40,035,000 |
Total Cash Past Year | 40,035,000 |
Total Cash Prior Year | 66,355,000 |
Net Cash Position Most Recent Quarter | -148,704,000 |
Net Cash Position Past Year | -148,704,000 |
Long Term Debt Past Year | 188,739,000 |
Long Term Debt Prior Year | 175,461,000 |
Total Debt Most Recent Quarter | 188,739,000 |
Equity to Debt Ratio Past Year | 0.09 |
Equity to Debt Ratio Most Recent Quarter | 0.09 |
Total Stockholder Equity Past Year | 18,395,000 |
Total Stockholder Equity Prior Year | -8,185,000 |
Total Stockholder Equity Most Recent Quarter | 18,395,000 |
Options |
|
Put/Call Ratio | 0.73 |
Has Options | Options Chain |
Liquidity Rating | |
Technical Analysis |
|
Yahoo Finance Chart | Yahoo Finance Chart |
MACD | 0.27 |
MACD Signal | 1.11 |
20-Day Bollinger Lower Band | 21.87 |
20-Day Bollinger Middle Band | 40.34 |
20-Day Bollinger Upper Band | 58.81 |
Beta | 1.25 |
RSI | 45.48 |
50-Day SMA | 47.17 |
200-Day SMA | 54.84 |
System |
|
Modified | 4/27/2024 12:02:22 AM EST |